Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

NGX:NEIMETH Ratios and Metrics

Market cap in millions NGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Jun 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2022	Sep 30, 2021
Market Capitalization	14,101	9,785	8,290	2,716	2,659	3,324
Market Cap Growth	54.40%	18.04%	205.24%	2.14%	-20.00%	-5.41%
Enterprise Value	17,080	11,901	9,264	5,237	4,683	5,412
Last Close Price	3.30	2.29	1.94	1.43	1.40	1.68
PE Ratio	-	-	-	-	-	12.28
PS Ratio	2.80	2.18	3.75	0.93	0.98	1.09
PB Ratio	7.98	5.92	3.27	3.49	2.43	2.35
P/TBV Ratio	8.05	5.99	3.27	3.49	2.43	2.35
P/FCF Ratio	70.80	-	-	-	-	1693.09
P/OCF Ratio	14.70	24.70	-	20.49	-	9.61
EV/Sales Ratio	3.39	2.65	4.19	1.79	1.73	1.78
EV/EBITDA Ratio	7.96	6.07	21.81	54.54	49.41	8.47
EV/EBIT Ratio	8.47	6.50	31.01	-	-	9.86
EV/FCF Ratio	85.75	-	-	-	-	2756.94
Debt / Equity Ratio	2.93	3.26	1.73	4.68	3.05	2.15
Debt / EBITDA Ratio	2.41	2.74	10.33	35.20	35.15	4.64
Debt / FCF Ratio	26.01	-	-	-	-	1551.72
Asset Turnover	0.47	0.41	0.27	-	0.43	0.48
Inventory Turnover	1.22	1.30	0.79	-	1.02	1.12
Quick Ratio	0.34	0.35	0.45	0.48	0.63	1.53
Current Ratio	0.61	0.58	0.76	1.00	1.24	2.28
Return on Equity (ROE)	-51.12%	-42.27%	-108.42%	-	-8.74%	20.13%
Return on Assets (ROA)	11.76%	10.33%	2.24%	-	-0.24%	5.41%
Return on Capital (ROIC)	19.84%	16.40%	3.29%	-	-0.35%	7.60%
Return on Capital Employed (ROCE)	89.00%	85.50%	9.80%	-	-	13.20%
Earnings Yield	-6.01%	-9.05%	-21.68%	-11.97%	-4.12%	8.14%
FCF Yield	1.41%	-3.13%	-20.62%	-41.87%	-45.31%	0.06%
Dividend Yield	-	-	-	-	-	4.17%
Payout Ratio	-	-	-	-	-	45.62%
Buyback Yield / Dilution	-2.79%	-	-125.00%	-	-	-
Total Shareholder Return	-	-	-125.00%	-	-	4.17%

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.